Search results
Results from the WOW.Com Content Network
The brain is very complex, and is composed of many different areas and types of tissue, or matter. The different functions of different tissues in the brain may be more or less susceptible to age-induced changes. [6] The brain matter can be broadly classified as either grey matter, or white matter.
Unfortunately, it is hard to provide a solid link between the shrinking brain and memory loss due to not knowing exactly which area of the brain has shrunk and what the importance of that area truly is in the aging process (Baddeley, Anderson, & Eysenck, 2015) Attempting to recall information or a situation that has happened can be very ...
Treatments with anticancer chemotherapeutic agents often are toxic to the cells of the brain, leading to memory loss and cognitive dysfunction that can persist long after the period of exposure. This condition, termed chemo brain, appears to be due to DNA damages that cause epigenetic changes in the brain that accelerate the brain aging process ...
Ageing (or aging in American English) is the process of becoming older. The term refers mainly to humans , many other animals , and fungi, whereas for example, bacteria, perennial plants and some simple animals are potentially biologically immortal . [ 1 ]
Carol A. Barnes is an American neuroscientist who is a Regents' Professor of psychology at the University of Arizona. [1] Since 2006, she has been the Evelyn F. McKnight Chair for Learning and Memory in Aging [2] and is director of the Evelyn F. McKnight Brain Institute. [3]
This page was last edited on 28 November 2024, at 15:14 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
Bryan Johnson (born August 22, 1977) is an American entrepreneur, [1] [2] venture capitalist, [3] writer and author. [4] He is the founder and former CEO of Kernel, a company creating devices that monitor and record brain activity, [5] [6] and OS Fund, a venture capital firm that invests in early-stage science and technology companies.
Michal Schwartz (born 1 January 1950) is a professor of neuroimmunology at the Weizmann Institute of Science.She is active in the field of neurodegenerative diseases, particularly utilizing the immune system to help the brain fight terminal neurodegenerative brain diseases, such as Alzheimer's disease and dementia.